Our findings in the present study demonstrate for the first time that miR-33b acts as a suppressive miRNA in HER2+ BC, which could inhibit tumor migration and invasion partly by impeding EMT through the repression of the MYC–EZH2 loop. The gene discussed is ERBB2; the disease is breast cancer.